{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:37:25Z","timestamp":1795081045296,"version":"4.10.2"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41585-025-00994-z","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:16:34Z","timestamp":1739888194000},"page":"427-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment strategies in human papillomavirus-related advanced penile cancer"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-2306","authenticated-orcid":false,"given":"Mattia","family":"Longoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-5488","authenticated-orcid":false,"given":"Christian D.","family":"Fankhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3677-6412","authenticated-orcid":false,"given":"Fausto","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-7165","authenticated-orcid":false,"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7227-7821","authenticated-orcid":false,"given":"Giuseppe","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. S.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EAU-YAU Penile and Testis Cancer Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fankhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"De Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fallara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Anselmo","family":"da Costa Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chorbi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Glombik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Grogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Paffenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Poterek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Territo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"994_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.21037\/tau.2017.05.19","volume":"6","author":"A Douglawi","year":"2017","unstructured":"Douglawi, A. & Masterson, T. A. Updates on the epidemiology and risk factors for penile cancer. Transl. Androl. Urol. 6, 785\u2013790 (2017).","journal-title":"Transl. Androl. Urol."},{"key":"994_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/120347540100500408","volume":"5","author":"TO Moore","year":"2001","unstructured":"Moore, T. O. et al. Human papillomavirus, smoking, and cancer. J. Cutan. Med. Surg. 5, 323\u2013328 (2001).","journal-title":"J. Cutan. Med. Surg."},{"key":"994_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/A:1011266405062","volume":"12","author":"HF Tsen","year":"2001","unstructured":"Tsen, H. F., Morgenstern, H., Mack, T. & Peters, R. K. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control\u00a012, 267\u2013277 (2001).","journal-title":"Cancer Causes Control"},{"key":"994_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/bjc.2012.583","volume":"108","author":"HTT Do","year":"2013","unstructured":"Do, H. T. T. et al. The etiologic role of human papillomavirus in penile cancers: a study in Vietnam. Br. J. Cancer 108, 229\u2013233 (2013).","journal-title":"Br. J. Cancer"},{"key":"994_CR5","doi-asserted-by":"publisher","DOI":"10.2196\/34874","volume":"8","author":"L Fu","year":"2022","unstructured":"Fu, L. et al. Global pattern and trends in penile cancer incidence: population-based study. JMIR Public Health Surveill. 8, e34874 (2022).","journal-title":"JMIR Public Health Surveill."},{"key":"994_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen, T. B. et al. Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 20, 145\u2013158 (2019).","journal-title":"Lancet Oncol."},{"key":"994_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10552-021-01493-3","volume":"33","author":"M Wenzel","year":"2022","unstructured":"Wenzel, M. et al. Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma. Cancer Causes Control\u00a033, 25\u201335 (2022).","journal-title":"Cancer Causes Control"},{"key":"994_CR8","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/hed.25810","volume":"41","author":"L Xu","year":"2019","unstructured":"Xu, L., Dahlstrom, K. R., Lairson, D. R. & Sturgis, E. M. Projected oropharyngeal carcinoma incidence among middle-aged US men. Head Neck 41, 3226\u20133234 (2019).","journal-title":"Head Neck"},{"key":"994_CR9","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","volume":"11","author":"L Bruni","year":"2023","unstructured":"Bruni, L. et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob. Health 11, e1345\u2013e1362 (2023).","journal-title":"Lancet Glob. Health"},{"key":"994_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59831-5","volume":"10","author":"CB Vieira","year":"2020","unstructured":"Vieira, C. B. et al. Profile of patients with penile cancer in the region with the highest worldwide incidence. Sci. Rep. 10, 2965 (2020).","journal-title":"Sci. Rep."},{"key":"994_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","volume":"83","author":"OR Brouwer","year":"2023","unstructured":"Brouwer, O. R. et al. European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update. Eur. Urol. 83, 548\u2013560 (2023).","journal-title":"Eur. Urol."},{"key":"994_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","volume":"7","author":"Anita Tomas","year":"2021","unstructured":"Tomas, Anita et al. Penile cancer. Nat. Rev. Dis. Primers\u00a07, 11 (2021). This comprehensive primer provides essential insights into the epidemiology, pathology and management strategies for penile cancer, highlighting the need for increased awareness and improved treatment protocols in this rare malignancy.","journal-title":"Nat. Rev. Dis. Primers"},{"key":"994_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.euf.2018.09.010","volume":"5","author":"B Schlenker","year":"2019","unstructured":"Schlenker, B. & Schneede, P. The role of human papilloma virus in penile cancer prevention and new therapeutic agents. Eur. Urol. Focus\u00a05, 42\u201345 (2019). The study emphasizes the association between HPV and penile cancer, advocating for preventive measures and innovative therapeutic approaches to mitigate this risk.","journal-title":"Eur. Urol. Focus"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"891623","DOI":"10.3389\/fonc.2022.891623","volume":"12","author":"X Deng","year":"2022","unstructured":"Deng, X. et al. Trends in incidence, mortality, and survival of penile cancer in the United States: a population-based study. Front. Oncol. 12, 891623 (2022).","journal-title":"Front. Oncol."},{"key":"994_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","volume":"191","author":"RS Djajadiningrat","year":"2014","unstructured":"Djajadiningrat, R. S. et al. Contemporary management of regional nodes in penile cancer \u2014 improvement of survival? J. Urol. 191, 68\u201373 (2014).","journal-title":"J. Urol."},{"key":"994_CR16","doi-asserted-by":"publisher","first-page":"103481","DOI":"10.1016\/j.esmoop.2024.103481","volume":"9","author":"A Muneer","year":"2024","unstructured":"Muneer, A. et al. Penile cancer: ESMO\u2013EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open\u00a09, 103481 (2024).","journal-title":"ESMO Open"},{"key":"994_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MOU.0000000000000719","volume":"30","author":"M Bandini","year":"2020","unstructured":"Bandini, M., Pederzoli, F. & Necchi, A. Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge. Curr. Opin. Urol. 30, 218\u2013222 (2020).","journal-title":"Curr. Opin. Urol."},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.eururo.2018.04.025","volume":"74","author":"J Chipollini","year":"2018","unstructured":"Chipollini, J., Necchi, A. & Spiess, P. E. Outcomes for patients with node-positive penile cancer: impact of perioperative systemic therapies and the importance of surgical intervention. Eur. Urol. 74, 241\u2013242 (2018).","journal-title":"Eur. Urol."},{"key":"994_CR19","doi-asserted-by":"publisher","first-page":"1055235","DOI":"10.3389\/fimmu.2022.1055235","volume":"13","author":"Y Tang","year":"2022","unstructured":"Tang, Y., Hu, X., Wu, K. & Li, X. Immune landscape and immunotherapy for penile cancer. Front. Immunol. 13, 1055235 (2022).","journal-title":"Front. Immunol."},{"key":"994_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.clon.2016.03.001","volume":"28","author":"C Cleary","year":"2016","unstructured":"Cleary, C. et al. Biological features of human papillomavirus-related head and neck cancers contributing to improved response. Clin. Oncol. 28, 467\u2013474 (2016).","journal-title":"Clin. Oncol."},{"key":"994_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4161\/epi.26881","volume":"9","author":"PMW van Kempen","year":"2014","unstructured":"van Kempen, P. M. W. et al. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics 9, 194\u2013203 (2014).","journal-title":"Epigenetics"},{"key":"994_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","volume":"20","author":"AA McBride","year":"2022","unstructured":"McBride, A. A. Human papillomaviruses: diversity, infection and host interactions. Nat. Rev. Microbiol. 20, 95\u2013108 (2022). The complexity of HPVs, their diverse interactions with hosts and their implications for diseases such as penile cancer are discussed in this review, underscoring the importance of understanding HPV biology for effective prevention strategies.","journal-title":"Nat. Rev. Microbiol."},{"key":"994_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2013.05.012","volume":"445","author":"K Van Doorslaer","year":"2013","unstructured":"Van Doorslaer, K. Evolution of the papillomaviridae. Virology 445, 11\u201320 (2013).","journal-title":"Virology"},{"key":"994_CR24","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","volume":"30","author":"A-B Moscicki","year":"2012","unstructured":"Moscicki, A.-B. et al. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 30, F24\u2013F33 (2012).","journal-title":"Vaccine"},{"key":"994_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel, C., Plummer, M., Vignat, J. & Franceschi, S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int. J. Cancer 141, 664\u2013670 (2017).","journal-title":"Int. J. Cancer"},{"key":"994_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/rmv.1822","volume":"25","author":"J Doorbar","year":"2015","unstructured":"Doorbar, J., Egawa, N., Griffin, H., Kranjec, C. & Murakami, I. Human papillomavirus molecular biology and disease association. Rev. Med. Virol. 25, 2\u201323 (2015).","journal-title":"Rev. Med. Virol."},{"key":"994_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrrev.2016.08.001","volume":"772","author":"S Mittal","year":"2017","unstructured":"Mittal, S. & Banks, L. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mutat. Res. Rev. Mutat. Res. 772, 23\u201335 (2017).","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"994_CR28","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1002\/cncr.34982","volume":"129","author":"B Nazha","year":"2023","unstructured":"Nazha, B. et al. Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers. Cancer 129, 3884\u20133893 (2023).","journal-title":"Cancer"},{"key":"994_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature16481","volume":"529","author":"D Martinez-Zapien","year":"2016","unstructured":"Martinez-Zapien, D. et al. Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53. Nature 529, 541\u2013545 (2016).","journal-title":"Nature"},{"key":"994_CR30","first-page":"02266","volume":"S0302-2838","author":"L Elst","year":"2024","unstructured":"Elst, L. et al. Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization. Eur. Urol. S0302-2838, 02266\u201302268 (2024).","journal-title":"Eur. Urol."},{"key":"994_CR31","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1128\/JVI.00537-17","volume":"91","author":"S DiGiuseppe","year":"2017","unstructured":"DiGiuseppe, S., Bienkowska-Haba, M., Guion, L. G. M., Keiffer, T. R. & Sapp, M. Human papillomavirus major capsid protein L1 remains associated with the incoming viral genome throughout the entry process. J. Virol. 91, e00537\u201317 (2017).","journal-title":"J. Virol."},{"key":"994_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/cancers12030646","volume":"12","author":"AR Ferreira","year":"2020","unstructured":"Ferreira, A. R., Ramalho, A. C., Marques, M. & Ribeiro, D. The interplay between antiviral signalling and carcinogenesis in human papillomavirus infections. Cancers 12, 646 (2020).","journal-title":"Cancers"},{"key":"994_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/viro.2002.1360","volume":"295","author":"L Florin","year":"2002","unstructured":"Florin, L., Sch\u00e4fer, F., Sotlar, K., Streeck, R. E. & Sapp, M. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 295, 97\u2013107 (2002).","journal-title":"Virology"},{"key":"994_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s11604-021-01231-4","volume":"40","author":"M Someya","year":"2022","unstructured":"Someya, M. et al. Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy. Jpn. J. Radiol. 40, 458\u2013465 (2022).","journal-title":"Jpn. J. Radiol."},{"key":"994_CR35","doi-asserted-by":"publisher","first-page":"1407649","DOI":"10.3389\/fimmu.2024.1407649","volume":"15","author":"S-Y Qi","year":"2024","unstructured":"Qi, S.-Y., Yang, M.-M., Li, C.-Y., Yu, K. & Deng, S.-L. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers. Front. Immunol. 15, 1407649 (2024).","journal-title":"Front. Immunol."},{"key":"994_CR36","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","volume":"23","author":"D Tang","year":"2023","unstructured":"Tang, D., Kang, R., Zeh, H. J. & Lotze, M. T. The multifunctional protein HMGB1: 50 years of discovery. Nat. Rev. Immunol. 23, 824\u2013841 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"994_CR37","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/ijc.28411","volume":"134","author":"AS Andersen","year":"2014","unstructured":"Andersen, A. S., Koldjaer S\u00f8lling, A. S., Ovesen, T. & Rusan, M. The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Int. J. Cancer 134, 2755\u20132763 (2014).","journal-title":"Int. J. Cancer"},{"key":"994_CR38","doi-asserted-by":"publisher","first-page":"19552","DOI":"10.1073\/pnas.1906102116","volume":"116","author":"J Sitz","year":"2019","unstructured":"Sitz, J. et al. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response. Proc. Natl Acad. Sci. USA 116, 19552\u201319562 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR39","doi-asserted-by":"publisher","first-page":"21573","DOI":"10.1073\/pnas.1906120116","volume":"116","author":"JE Leeman","year":"2019","unstructured":"Leeman, J. E. et al. Human papillomavirus 16 promotes microhomology-mediated end-joining. Proc. Natl Acad. Sci. USA 116, 21573\u201321579 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR40","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-13-0587","volume":"73","author":"RJ Kimple","year":"2013","unstructured":"Kimple, R. J. et al. Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res. 73, 4791\u20134800 (2013).","journal-title":"Cancer Res."},{"key":"994_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry, C. et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. 100, 261\u2013269 (2008).","journal-title":"J. Natl Cancer Inst."},{"key":"994_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang, K. K. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24\u201335 (2010).","journal-title":"N. Engl. J. Med."},{"key":"994_CR43","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/jnci\/djaa184","volume":"113","author":"N Riaz","year":"2021","unstructured":"Riaz, N. et al. Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial. J. Natl Cancer Inst. 113, 742\u2013751 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"994_CR44","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1200\/JCO.2021.39.15_suppl.6019","volume":"39","author":"NY Lee","year":"2021","unstructured":"Lee, N. Y. et al. The 30 ROC trial: precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer. J. Clin. Oncol. 39, 6019\u20136019 (2021).","journal-title":"J. Clin. Oncol."},{"key":"994_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/JCO.21.01752","volume":"40","author":"RL Ferris","year":"2022","unstructured":"Ferris, R. L. et al. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311). J. Clin. Oncol. 40, 138\u2013149 (2022).","journal-title":"J. Clin. Oncol."},{"key":"994_CR46","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.3390\/cancers13194912","volume":"13","author":"G Anderson","year":"2021","unstructured":"Anderson, G. et al. An updated review on head and neck cancer treatment with radiation therapy. Cancers 13, 4912 (2021).","journal-title":"Cancers"},{"key":"994_CR47","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","volume":"18","author":"B Lacas","year":"2017","unstructured":"Lacas, B. et al. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 18, 1221\u20131237 (2017).","journal-title":"Lancet Oncol."},{"key":"994_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002568","volume":"9","author":"RL Ferris","year":"2021","unstructured":"Ferris, R. L. et al. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial. J. Immunother. Cancer 9, e002568 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"994_CR49","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/jamaoncol.2024.1530","volume":"10","author":"AJ Rosenberg","year":"2024","unstructured":"Rosenberg, A. J. et al. Neoadjuvant nivolumab plus chemotherapy followed by response-adaptive therapy for HPV+ oropharyngeal cancer: OPTIMA II phase 2 open-label nonrandomized controlled trial. JAMA Oncol. 10, 923\u2013931 (2024).","journal-title":"JAMA Oncol."},{"key":"994_CR50","doi-asserted-by":"publisher","first-page":"742215","DOI":"10.3389\/fendo.2021.742215","volume":"12","author":"A Rakotomalala","year":"2021","unstructured":"Rakotomalala, A., Escande, A., Furlan, A., Meignan, S. & Lartigau, E. Hypoxia in solid tumors: how low oxygenation impacts the \u2018Six Rs\u2019 of radiotherapy. Front. Endocrinol. 12, 742215 (2021).","journal-title":"Front. Endocrinol."},{"key":"994_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijrobp.2016.04.027","volume":"96","author":"N Lee","year":"2016","unstructured":"Lee, N. et al. A strategy of using intra-treatment hypoxia imaging to selectively and safely guide radiation dose deescalation concurrent with chemotherapy for loco-regionally advanced human papillomavirus-related oropharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 96, 9\u201317 (2016).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"994_CR52","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1200\/JCO.23.01308","volume":"42","author":"NY Lee","year":"2024","unstructured":"Lee, N. Y. et al. Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma. J. Clin. Oncol. 42, 940\u2013950 (2024).","journal-title":"J. Clin. Oncol."},{"key":"994_CR53","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1200\/JCO.22.02894","volume":"41","author":"HM de Vries","year":"2023","unstructured":"de Vries, H. M. et al. Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis (The PERICLES Study): a phase II trial. J. Clin. Oncol. 41, 4872\u20134880 (2023). In this phase II trial, the efficacy of atezolizumab combined with radiotherapy in treating advanced penile squamous cell carcinoma was investigated, potentially paving the way for novel immunotherapeutic strategies in this challenging disease.","journal-title":"J. Clin. Oncol."},{"key":"994_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijrobp.2023.03.066","volume":"117","author":"SR Ottenhof","year":"2023","unstructured":"Ottenhof, S. R. et al. A prospective study of chemoradiotherapy as primary treatment in patients with locoregionally advanced penile carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 117, 139\u2013147 (2023). In this prospective study, chemoradiotherapy is evaluated as a primary treatment option for locoregionally advanced penile carcinoma, aiming to enhance treatment outcomes and inform clinical practice guidelines.","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"994_CR55","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.euo.2020.10.011","volume":"4","author":"M Bandini","year":"2021","unstructured":"Bandini, M. et al. Association between human papillomavirus infection and outcome of perioperative nodal radiotherapy for penile carcinoma. Eur. Urol. Oncol. 4, 802\u2013810 (2021). This retrospective study highlights the correlation between HPV status and treatment outcomes in patients undergoing perioperative nodal radiotherapy for penile carcinoma, suggesting that HPV status could be a critical factor in tailoring therapy decisions.","journal-title":"Eur. Urol. Oncol."},{"key":"994_CR56","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00345-018-2280-0","volume":"36","author":"Z Yuan","year":"2018","unstructured":"Yuan, Z. et al. The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer. World J. Urol. 36, 1431\u20131440 (2018). In this study, how HPV status influences the effectiveness of chemoradiotherapy in controlling locoregional penile cancer is investigated, providing insights into personalized treatment approaches based on viral status.","journal-title":"World J. Urol."},{"key":"994_CR57","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41585-020-0359-z","volume":"17","author":"AM Aydin","year":"2020","unstructured":"Aydin, A. M. et al. Understanding genomics and the immune environment of penile cancer to improve therapy. Nat. Rev. Urol. 17, 555\u2013570 (2020).","journal-title":"Nat. Rev. Urol."},{"key":"994_CR58","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1634\/theoncologist.2019-0244","volume":"25","author":"SJ Klempner","year":"2020","unstructured":"Klempner, S. J. et al. Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: a review of current evidence. Oncologist 25, e147\u2013e159 (2020).","journal-title":"Oncologist"},{"key":"994_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.48002","volume":"6","author":"A Necchi","year":"2023","unstructured":"Necchi, A. et al. Genomic profiles and clinical outcomes of penile squamous cell carcinoma with elevated tumor mutational burden. JAMA Netw. Open\u00a06, e2348002 (2023). This research identifies genomic profiles associated with elevated TMB in patients with PSCC, offering potential biomarkers that could guide treatment decisions and prognostic assessments in clinical settings.","journal-title":"JAMA Netw. Open"},{"key":"994_CR60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.humpath.2023.10.003","volume":"142","author":"B Tekin","year":"2023","unstructured":"Tekin, B. et al. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma. Hum. Pathol. 142, 42\u201350 (2023).","journal-title":"Hum. Pathol."},{"key":"994_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euros.2022.12.008","volume":"49","author":"GD Grass","year":"2023","unstructured":"Grass, G. D. et al. An analysis of nectin-4 (PVRL4) in penile squamous cell carcinoma. Eur. Urol. Open Sci. 49, 1\u20135 (2023).","journal-title":"Eur. Urol. Open Sci."},{"key":"994_CR62","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06353906 (2024)."},{"key":"994_CR63","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06104618 (2024)."},{"key":"994_CR64","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura, E. A. et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N. Engl. J. Med. 372, 711\u2013723 (2015).","journal-title":"N. Engl. J. Med."},{"key":"994_CR65","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1590\/s1677-5538.ibju.2018.05.02","volume":"44","author":"BRI Voris","year":"2018","unstructured":"Voris, B. R. I., Visintin, C. D. N. & Reis, L. O. HPV vaccination is fundamental for reducing or erradicate penile cancer opinion: YES. Int. Braz. J. Urol. 44, 859\u2013861 (2018).","journal-title":"Int. Braz. J. Urol."},{"key":"994_CR66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/pathogens9050403","volume":"9","author":"CD James","year":"2020","unstructured":"James, C. D., Morgan, I. M. & Bristol, M. L. The relationship between estrogen-related signaling and human papillomavirus positive cancers. Pathogens 9, 403 (2020).","journal-title":"Pathogens"},{"key":"994_CR67","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ijc.2910480410","volume":"48","author":"J Monsonego","year":"1991","unstructured":"Monsonego, J. et al. Estrogen and progesterone receptors in cervical human papillomavirus related lesions. Int. J. Cancer 48, 533\u2013539 (1991).","journal-title":"Int. J. Cancer"},{"key":"994_CR68","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","volume":"2","author":"M Schiffman","year":"2016","unstructured":"Schiffman, M. et al. Carcinogenic human papillomavirus infection. Nat. Rev. Dis. Primers\u00a02, 16086 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"994_CR69","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","volume":"69","author":"L Alemany","year":"2016","unstructured":"Alemany, L. et al. Role of human papillomavirus in penile carcinomas worldwide. Eur. Urol. 69, 953\u2013961 (2016).","journal-title":"Eur. Urol."},{"key":"994_CR70","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","volume":"27","author":"AM Udager","year":"2016","unstructured":"Udager, A. M. et al. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann. Oncol. 27, 1706\u20131712 (2016).","journal-title":"Ann. Oncol."},{"key":"994_CR71","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","volume":"197","author":"SR Ottenhof","year":"2017","unstructured":"Ottenhof, S. R. et al. Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status. J. Urol. 197, 690\u2013697 (2017).","journal-title":"J. Urol."},{"key":"994_CR72","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3389\/fimmu.2018.01253","volume":"9","author":"SR Ottenhof","year":"2018","unstructured":"Ottenhof, S. R. et al. The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma. Front. Immunol. 9, 1253 (2018).","journal-title":"Front. Immunol."},{"key":"994_CR73","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","volume":"27","author":"FL Sand","year":"2018","unstructured":"Sand, F. L., Rasmussen, C. L., Frederiksen, M. H., Andersen, K. K. & Kjaer, S. K. Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis. Cancer Epidemiol. Biomark. Prev. 27, 1123\u20131132 (2018).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"994_CR74","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","volume":"14","author":"K Zargar-Shoshtari","year":"2016","unstructured":"Zargar-Shoshtari, K. et al. Clinical significance of p53 and p16ink4a status in a contemporary North American penile carcinoma cohort. Clin. Genitourin. Cancer 14, 346\u2013351 (2016).","journal-title":"Clin. Genitourin. Cancer"},{"key":"994_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017517","volume":"6","author":"E Stankiewicz","year":"2011","unstructured":"Stankiewicz, E. et al. Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS ONE 6, e17517 (2011).","journal-title":"PLoS ONE"},{"key":"994_CR76","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05686226 (2024)."},{"key":"994_CR77","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04708470 (2025)."},{"key":"994_CR78","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05639972 (2024)."},{"key":"994_CR79","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06544720 (2024)."},{"key":"994_CR80","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06505551 (2024)."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-00994-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-00994-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-00994-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:13:52Z","timestamp":1751631232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-00994-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-00994-z","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"7 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}